Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 6

Conditions

Colorectal Neoplasms 145Head and Neck Neoplasms 79Squamous Cell Carcinoma of Head and Neck 68Rectal Neoplasms 46Colonic Neoplasms 42Carcinoma, Non-Small-Cell Lung 39Neoplasm Metastasis 35Neoplasms 25Carcinoma, Squamous Cell 20Pancreatic Neoplasms 17Lung Neoplasms 16Esophageal Neoplasms 15Stomach Neoplasms 12Recurrence 11Laryngeal Neoplasms 11Mouth Neoplasms 10Oropharyngeal Neoplasms 8Esophageal Squamous Cell Carcinoma 8Breast Neoplasms 8Adenocarcinoma Of Esophagus 8Tongue Neoplasms 7Uterine Cervical Neoplasms 6Nasopharyngeal Carcinoma 6Laryngeal Diseases 6Hypopharyngeal Neoplasms 6Colorectal Cancer Metastatic 6Carcinoma 6Adenocarcinoma of Lung 6Salivary Gland Neoplasms 5Cholangiocarcinoma 4

Interventions

Cisplatin 51Gemcitabine 26toripalimab 20Radiotherapy, Intensity-Modulated 19Fluorouracil 16Capecitabine 16camrelizumab 15Docetaxel 14nimotuzumab 12Radiotherapy 10Drug Therapy 10apatinib 9Nivolumab 9sintilimab 8endostar protein 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Immune Checkpoint Inhibitors 7tislelizumab 6spartalizumab 6Chemoradiotherapy 6Cetuximab 6Bevacizumab 6pembrolizumab 5nedaplatin 5S 1 (combination) 5Radiation 5Paclitaxel 5Endostatins 5anlotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Nasopharyngeal Carcinoma × Cetuximab × Clear all
NCT04508816 2022-04-04

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Fudan University

Phase 2 Completed
45 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01230476 2019-10-07

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

University of Malaya

Phase 2 Terminated
3 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01326559 2017-08-16

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Hong Kong Nasopharyngeal Cancer Study Group Limited

Phase 2 Completed
33 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01271439 2013-08-13

REPLACE

Sun Yat-sen University

Phase 2 Completed
60 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01614938 2012-06-08

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

Fudan University

Phase 2 Unknown
46 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00700440 2010-03-26

ENCORE

Sun Yat-sen University

Phase 2 Completed
100 enrolled 4 charts
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡